A quality improvement program to reduce potential overtreatment of diabetes among veterans at high risk of hypoglycemia

Diabetes Spectrum

Volumn 30, Issue 3, 2017, Pages 211-216

  Vimalananda, Varsha G ^a,b   Desotto, Kristine ^c   Chen, Techieh ^c   Mullakary, Jenny ^d   Schlosser, James ^e   Archambeault, Cliona ^f   Peck, Jordan ^g   Cassidy, Hannah ^h   Conlin, Paul R ^i,j   Evans, Stewart ^e   McConnell, Mark ^a   Shirley, Eric ^k,l  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c New England Veterans Engineering Resource Center   (United States)

^d MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^e VA New England Healthcare System   (United States)

^f UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^g MAINE MEDICAL CENTER   (United States)

^h NORTHEASTERN UNIVERSITY   (United States)

ⁱ VA BOSTON HEALTHCARE SYSTEM   (United States)

^j HARVARD MEDICAL SCHOOL   (United States)

^k VA MEDICAL CENTER   (United States)

^l DARTMOUTH MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85027525702     PISSN: 10409165     EISSN: 19447353     Source Type: Journal    
DOI: 10.2337/ds16-0006     Document Type: Article

References (22)

1. Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572
2. Hemmelgarn B, Levesque LE, Suissa S. Anti-diabetic drug use and the risk of motor vehicle crash in the elderly. Can J Clin Pharmacol 2006;13:e112-e120
3. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559
4. Huang ES, Zhang Q, Gandra N, Chin MH, Meltzer DO. The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis. Ann Intern Med 2008;149:11-19
5. Zoungas S, Patel A, Chalmers J, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010;363:1410-1418
6. Kirsh SR, Aron DC. Choosing targets for glycaemia, blood pressure and low-density lipoprotein cholesterol in elderly individuals with diabetes mellitus. Drugs Aging 2011;28:945-960
7. Feil DG, Rajan M, Soroka O, Tseng CL, Miller DR, Pogach LM. Risk of hypoglycemia in older veterans with dementia and cognitive impairment: implications for practice and policy. J Am Geriatr Soc 2011;59:2263-2272
8. Moore TJ, Cohen MR, Furberg CD. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. Arch Intern Med 2007;167:1752-1759
9. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011;365:2002-2012
10. Lipska KJ, Ross JS, Wang Y, et al. National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011. JAMA Intern Med 2014;1116-1124
11. Weitzman ER, Kelemen S, Quinn M, Eggleston EM, Mandl KD. Participatory surveillance of hypoglycemia and harms in an online social network. JAMA Intern Med 2013;173:345-351
12. Green AJ, Fox KM, Grandy S. Self-reported hypoglycemia and impact on quality of life and depression among adults with type 2 diabetes mellitus. Diabetes Res Clin Pract 2012;96:313-318
13. U. S. Department of Veterans Affairs. VA/DoD clinical practice guideline for the management of diabetes mellitus (2010). Available from http://www.healthquality. va.gov/guidelines/CD/diabetes. Accessed 3 February 2016
14. American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care 2014;37(Suppl. 1):S14-S80
15. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364-1379
16. Sussman JB, Kerr EA, Saini SD, et al. Rates of deintensification of blood pressure and glycemic medication treatment based on levels of control and life expectancy in older patients with diabetes mellitus. JAMA Intern Med 2015;175:1942-1949
17. Miller DR, Safford MM, Pogach LM. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care 2004;27(Suppl. 2):B10-B21
18. Tseng CL, Soroka O, Maney M, Aron DC, Pogach LM. Assessing potential glycemic overtreatment in persons at hypoglycemic risk. JAMA Intern Med 2014;174:259-268
19. Thorpe CT, Gellad WF, Good CB, et al. Tight glycemic control and use of hypoglycemic medications in older veterans with type 2 diabetes and comorbid dementia. Diabetes Care 2015;38:588-595
20. American Board of Internal Medicine Foundation. Choosing Wisely, an initiative of the ABIM Foundation. Available from http://www.choosingwisely.org. Accessed 6 January 2016
21. Caverly TJ, Fagerlin A, Zikmund-Fisher BJ, et al. Appropriate prescribing for patients with diabetes at high risk for hypoglycemia: national survey of Veterans Affairs health care professionals. JAMA Intern Med 2015;175:1994-1996
22. Fung CH, Woods JN, Asch SM, Glassman P, Doebbeling BN. Variation in implementation and use of computerized clinical reminders in an integrated healthcare system. Am J Manag Care 2004;10:878-885